Company · CIK 2084031

# Regenlab USA Inc.

| CIK | [2084031](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002084031) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | RGNA |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-299144 | First-time registration Filed | 2026-09-25 | 2026-09-25 | 1 |

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-25 | [S-1](https://www.sec.gov/Archives/edgar/data/2084031/000182912626010431/0001829126-26-010431-index.htm) Registration filed | 333-299144 | 0001829126-26-010431 |
| 2025-10-20 | [DRS](https://www.sec.gov/Archives/edgar/data/2084031/000182912625008214/0001829126-25-008214-index.htm) Draft made public | 377-08587 | 0001829126-25-008214 |

[All filings of this company](https://equitycapital.markets/filings?cik=2084031) · [CSV](https://equitycapital.markets/filings.csv?cik=2084031)

---
Source page: https://equitycapital.markets/company/2084031 · Data: U.S. SEC EDGAR · CC BY 4.0